Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jiangsu Hengrui Pharmaceuticals
Pharma
COINS Act, Hengrui, Samsung Biologics—Fierce Pharma Asia
The Treasury Department closed in on U.S. investments in China life-sci. Hengrui discussed its secret sauce. Samsung Bio averted a strike, for now.
Fraiser Kansteiner
Oct 23, 2026 8:42am
AZ-Summit, Novo-Hengrui, Merck—Fierce Pharma Asia
Oct 2, 2026 9:35am
Legend Biotech, Merck, Otsuka—Fierce Pharma Asia
Jul 31, 2026 9:00am
2 FDA citations trouble Hengrui, Elevar’s liver cancer combo
Jul 28, 2026 3:02pm
GSK-Hansoh, Merck-Kelun, AZ-Dizal—Fierce Pharma Asia
Jul 17, 2026 9:38am
Huahai poaches quality chief from Hengrui amid FDA citations
Jul 16, 2026 4:11pm
